Robin Roberts Praises 'Superhero' Stem Cell Donors on 12-Year Anniversary of GMA Return
The 'Good Morning America' host Robin Roberts highlighted the urgent need for stem cell donations — an outpatient process ...
W.F. West students host enrollment events in honor of classmate battling rare disorder, Chehalis woman who fought leukemia
In honor of a W.F. West High School student who is battling a rare bone marrow disorder and a Chehalis woman who fought ...
Robin Roberts marks 12 years since 'GMA' return after stem cell transplant
"Good Morning America" co-anchor Robin Roberts is marking 12 years since she returned to the anchor desk after receiving a ...
Cure Today10d
Moving Slower and Slower After Myelodysplastic Syndrome
I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to ...
Too Old to Operate1d
Karyotype Evolution in MDS and AML With TP53 Mutations
The following is a summary of “Karyotype evolution of myelodysplastic syndrome and acute myeloid leukemia with TP53 mutations,” published in the February 2025 issue of the International Journal of ...
The American Journal of Managed Care1d
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...
Targeted Oncology12d
Evaluating Agents to Manage Low-Risk Myelodysplastic Syndrome
Saeed Sadeghi, MD, discusses treatment options in low-risk myelodysplastic syndrome at a Case-Based Roundtable event.
Business Wire12d
Orca Bio’s Orca-T® Meets Primary Endpoint in the Pivotal Precision-T Phase 3 Clinical Study for Hematologic Malignancies
Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.